Mobilizing and Maintaining Clinical Trials in Midst of War
Ukraine invasion tests the resiliency and quick action of CROs and sponsors.
The Implications of Inflation for Drug Development
Experts gauge threat level for global trials amid staffing and funding issues.
Implementing Numeric Rating and Visual Analog Scales in an eCOA Solution
Despite prevalent use in electronic devices, NRS and VAS are often implemented suboptimally.
‘Dogma’ About Innovation vs. Access Impeding EU Fixes for Rare Diseases
Rare disease stakeholders speak out ahead of anticipated EU changes.
When Does Patient Centricity Equal Burden?
Industry experts reinforce not putting all eyes on the patient.
Applied Clinical Trials November 2022 Issue (PDF)
Click the title above for a link to open the Applied Clinical Trials November 2022 issue in an interactive PDF format.
The State of Data FAIRification in Clinical Research
Study shows more support is needed for clinical teams to ‘FAIRify’ their data.
“Culture of Quality” In Action
Sheri Kuss, clinical quality group lead at Pfizer, discusses the new "culture of quality" in clinical trials.
FDA Expands Oversight of Cell and Gene Therapies
CBER maps modernization plan to handle surge in research and applications.
Anticipating Careless Responders in Survey Design and Analysis
Clinical trials must rely on internet surveys to incorporate the needs of industry and patients, but how can results be improved?
Towards a Global Implementation of eConsent in Clinical Trials
All stakeholders must play part in increasing implementation.
